Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

An Overview of Biopolymer-Based Graphene Nanocomposites for Biotechnological Applications

Binaymotlagh R., Chronopoulou L., Palocci C.

Narrative Review on Chronic Wound, published in Materials (Basel) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Materials (Basel) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40649466
PMCID
PMC12250760
DOI
10.3390/ma18132978
Citations
4

Abstract (original English)

Bio-nanocomposites represent an advanced class of materials that combine the unique properties of nanomaterials with biopolymers, enhancing mechanical, electrical and thermal properties while ensuring biodegradability, biocompatibility and sustainability. These materials are gaining increasing attention, particularly in biomedical applications, due to their ability to interact with biological systems in ways that conventional materials cannot. Graphene and graphene oxide (GO), two of the most well-known nanocarbon-based materials, have garnered substantial interest in bio-nanocomposite research because of their extraordinary properties such as high surface area, excellent electrical conductivity, mechanical strength and biocompatibility. The integration of graphene-based nanomaterials within biopolymers, such as polysaccharides and proteins, forms a new class of bio-nanocomposites that can be tailored for a wide range of biological applications. This review explores the synthesis methods, properties and biotechnological applications of graphene-based bio-nanocomposites, with a particular focus on polysaccharide-based and protein-based composites. Emphasis is placed on the biotechnological potential of these materials, including drug delivery, tissue engineering, wound healing, antimicrobial activities and industrial food applications. Additionally, biodegradable polymers such a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research